| SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05020925) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-01 |
| Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT04781088) | Floor Backes, MD | 2021-09-01 |
| Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome (NCT04909879) | Sorrento Therapeutics, Inc. | 2021-09-01 |
| Potential Drug Interactions With Bisoprolol in Egyptian Patients With ACS (NCT05536284) | Damanhour University | 2021-09-01 |
| Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL (NCT04676789) | Sun Yat-sen University | 2021-09-01 |
| INvestigating TELmisartin Study (NCT04715763) | University of Hawaii | 2021-09-01 |
| A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS) (NCT04922957) | Enlivex Therapeutics Ltd. | 2021-09-01 |
| BBV152/BBV154 Heterologus Prime-Boost Study (NCT05639998) | Bharat Biotech International Limited | 2021-09-01 |
| Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study (NCT04906681) | PXL University College | 2021-09-01 |
| CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type (NCT05218408) | Celularity Incorporated | 2021-09-01 |
| Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC (NCT04983550) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-09-01 |
| Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC (NCT04919811) | Nuvation Bio Inc. | 2021-09-01 |
| A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines (NCT05013424) | Allergan | 2021-09-01 |
| Acute Changes In Thermal Pain Response Following Single Oral Dose of Beta-Cary (NCT04794205) | Hartford Hospital | 2021-09-01 |
| A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma (NCT04722601) | University of Chicago | 2021-09-01 |
| Examining the Effectiveness of a Critical Time Intervention to Stabilize Trajectories Out of Homelessness for Youth (NCT04755361) | Centre for Addiction and Mental Health | 2021-09-01 |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas (NCT04906876) | Brown University | 2021-09-01 |
| A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (NCT05010525) | Shanghai Antengene Corporation Limited | 2021-09-01 |
| A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE) (NCT04395456) | Amyndas Pharmaceuticals S.A. | 2021-09-01 |
| Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome. (NCT04994951) | The First Affiliated Hospital of Zhejiang Chinese Medical University | 2021-09-01 |
| Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication (NCT05003492) | Amr kamel khalil Ahmed | 2021-09-01 |
| Ropeginterferon Alfa 2b for Early Myelofibrosis (NCT04988815) | The University of Hong Kong | 2021-09-01 |
| Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma (NCT05448885) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-09-01 |
| Clinical And Cost- Effectiveness of Allium Sativum Oil (Garlic Oil ) Versus Mineral Trioxide Aggregate in Primary Molars Pulpotomy in Group of Egyptian Children : A Randomised Clinical Pilot Study. (NCT04903808) | Cairo University | 2021-09-01 |
| A Study of AL102 in Patients With Progressing Desmoid Tumors (NCT04871282) | Immunome, Inc. | 2021-09-01 |
| Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC (NCT05077839) | Tianjin Medical University Cancer Institute and Hospital | 2021-09-01 |
| Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (NCT05121870) | Beijing 302 Hospital | 2021-09-01 |
| Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis (NCT05573204) | Tanta University | 2021-09-01 |
| TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer. (NCT05013697) | Henan Cancer Hospital | 2021-09-01 |
| Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. (NCT05033587) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-09-01 |
| Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma (NCT04724226) | Sun Yat-sen University | 2021-09-01 |
| Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus (NCT04389580) | Kafrelsheikh University | 2021-09-01 |
| The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients (NCT05023863) | Ain Shams University | 2021-09-01 |
| Effect of Early Administration of TXA in Adult Hip Fractures (NCT05047133) | Ascension Health | 2021-09-01 |
| Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination (NCT04930770) | Maria Joyera Rodríguez | 2021-09-01 |
| Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients. (NCT04729595) | Adamis Pharmaceuticals Corporation | 2021-09-01 |
| Comparing Haloperidol and Olanzapine in Treating Terminal Delirium (NCT04750395) | HCA Hospice Care | 2021-09-01 |
| Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients Undergoing Caesarean Section (NCT05202574) | Minia University | 2021-09-01 |
| TAS-102 and Anlotinib in ≥3 Lines mGC (NCT05029102) | Zhejiang University | 2021-09-01 |
| Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer (NCT05086627) | Hebei Medical University Fourth Hospital | 2021-09-01 |
| Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks (NCT05610969) | University of Pennsylvania | 2021-09-01 |
| Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer (NCT04827953) | Nelum Corp | 2021-09-01 |
| IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients (NCT05104762) | Assiut University | 2021-09-01 |
| Efficacy of Ivermectin in COVID-19 (NCT05076253) | Bangkok Metropolitan Administration Medical College and Vajira Hospital | 2021-09-01 |
| Cilostazol for HFpEF (NCT05126836) | University of Minnesota | 2021-09-01 |
| S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma (NCT04989985) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-09-01 |
| To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue (NCT04593758) | Cornerstone Pharmaceuticals | 2021-09-01 |
| A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy (NCT04814875) | THERAPIM PTY LTD | 2021-09-01 |
| The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer (NCT05075512) | Zhejiang Cancer Hospital | 2021-09-01 |
| Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study. (NCT06239389) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2021-09-01 |
| Salt-Sensitivity and Immunity Cell Activation (NCT03753204) | Vanderbilt University Medical Center | 2021-09-01 |
| Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. (NCT04949386) | SolAeroMed Inc. | 2021-09-01 |
| High Dose Bupropion for Smoking Cessation - Pilot Study (NCT03326128) | University of Southern California | 2021-09-01 |
| Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer (NCT05120622) | University of British Columbia | 2021-09-01 |
| Evaluating Effects of Curcumin in Moderate to Severe Asthmatics (NCT04353310) | Loma Linda University | 2021-09-01 |
| Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL (NCT04913103) | Czech Lymphoma Study Group | 2021-09-01 |
| Management of Occlusal Caries Using Silver Modified Atraumatic Restorative Treatment Versus Atraumatic Restorative Treatment (NCT04354636) | Cairo University | 2021-09-01 |
| Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy (NCT05001763) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-09-01 |
| Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma (NCT05014100) | Puyang Oilfield General Hospital | 2021-09-01 |
| PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) (NCT04842331) | Thirty Respiratory Limited | 2021-09-01 |
| The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC (NCT05042336) | Sichuan University | 2021-09-01 |
| Flat Polypropylene Mesh in the Treatment of Uterine and Recurrent or Advanced Pelvic Organ Prolapse (NCT06225375) | Michigan Institution of Women's Health PC | 2021-09-01 |
| New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT05029141) | The First Affiliated Hospital of Soochow University | 2021-09-01 |
| Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand (NCT05003596) | Robert Wood Johnson Barnabas Health | 2021-09-01 |
| OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (NCT04789239) | Michael Fu | 2021-09-01 |
| A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC. (NCT05005468) | Shanghai Chest Hospital | 2021-09-01 |
| Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer (NCT05009953) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-09-01 |
| Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome (NCT05536271) | Damanhour University | 2021-09-01 |
| Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study) (NCT04817540) | Gangnam Severance Hospital | 2021-09-01 |
| MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (NCT03986086) | Nelson Chao | 2021-09-01 |
| Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma (NCT03766178) | The First Affiliated Hospital of Zhengzhou University | 2021-09-01 |
| Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients (NCT04298151) | Cairo University | 2021-09-01 |
| Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease (NCT05012631) | Children's Hospital Medical Center, Cincinnati | 2021-09-01 |
| Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma (NCT04850222) | University of Florida | 2021-09-01 |
| Xenon MRI Pulm Hypertension (NCT04991454) | Bastiaan Driehuys | 2021-09-01 |
| GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC (NCT05019677) | Fudan University | 2021-09-01 |
| Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL) (NCT04692155) | University of Alabama at Birmingham | 2021-08-31 |
| Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis (NCT07113574) | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 2021-08-31 |
| A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer (NCT05093907) | BeyondBio Inc. | 2021-08-31 |
| Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis (NCT03745417) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2021-08-31 |
| Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) (NCT05016882) | Novo Nordisk A/S | 2021-08-31 |
| The University of Michigan Wellness for Liver Health Study (NCT05010070) | University of Michigan | 2021-08-31 |
| Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery (NCT05005715) | Seoul National University Hospital | 2021-08-31 |
| SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT05445154) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-31 |
| Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors (NCT04980690) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2021-08-31 |
| Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy (NCT05007262) | Guizhou Bailing Group Pharmaceutical Co Ltd | 2021-08-31 |
| Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (NCT05065970) | HI-Bio, A Biogen Company | 2021-08-31 |
| Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy (NCT05063877) | Equilibre Biopharmaceuticals B.V. | 2021-08-31 |
| 18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer (NCT04733768) | University of Alberta | 2021-08-31 |
| High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers (NCT05011383) | VA Office of Research and Development | 2021-08-31 |
| A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China (NCT05017480) | Connect Biopharm LLC | 2021-08-31 |
| Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC (NCT05055583) | Tang-Du Hospital | 2021-08-31 |
| A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL. (NCT04923048) | Genor Biopharma Co., Ltd. | 2021-08-31 |
| A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults (NCT05037097) | Arcturus Therapeutics, Inc. | 2021-08-30 |
| Emodepside Phase II Trial for Treatment of Onchocerciasis (NCT05180461) | Drugs for Neglected Diseases | 2021-08-30 |
| A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty (NCT05034952) | Vertex Pharmaceuticals Incorporated | 2021-08-30 |
| A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer (NCT04945733) | Janssen Pharmaceutical K.K. | 2021-08-30 |
| Feasibility of [11C]Acetate-PET in LAM and TSC (NCT05467397) | Brigham and Women's Hospital | 2021-08-30 |
| Promoting Cervical Cancer Screening Through the Advocacy of Screened Women (NCT04960748) | RAND | 2021-08-30 |
| BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors (NCT04819373) | Eikon Therapeutics | 2021-08-30 |